Medicine & TechnologyFollowing the review of one volunteer's death in Astrazeneca and Oxford's COVID-19 vaccine trial, authorities said the clinical trials would continue.
The Oxford-AstraZeneca and CanSino vaccine candidates have both shown promising results in their early trials. As they now both enter phase three clinical trials, experts are hopeful that the vaccine candidates would continue to produce good results.
Professor Sarah Gilbert, who leads Oxford University's trial for its coronavirus vaccine candidate, says their jab could provide long-term immunity, which could last for several years. Furthermore, she says it could even give off antibodies three times more than a person who recovered from COVID-19.
The WHO announced on Monday the suspension of trials involving the antimalarial drug, hydroxychloroquine. However, an Oxford trial claims to be continuing despite the organization's previous order. Click the link above to learn more.
Oxford develops a new portable device that analyzes swab tests in about an hour. Weeks from now, the mass screening will possibly reach a new breakthrough.
The United Kingdom reportedly turned down an antibody test, among nine others, despite seeing promising results in patients. Until the government finds a test that is good enough, it won't start mass antibody testing.
A researcher at the Oxford University has discovered a water transition in space, which has never seen before and will provide a deeper understanding of the universe.
QS World University Rankings recently released the list of top universities in the world for 2015 with Massachusetts Institute of Technology retaining its top position while the rest of the institutions shuffled.